XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 26.70

-0.8%

Jan 23 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (9434)	3/30/1999 7:17:00 AM
From: Robert K.	Read Replies (1) of 17367

It aint a phase 2 George.(IMo) What do they call it? When did they start seeking volunteers? Before you all go badmouthing EM and the company for their incommunication>ask yourselves this.> Why would the company say nothing? Under what circumstances? Why? What more is up their sleeves?(think hard on that ) That said the endotoxin paper is in print.(ask xoma).>>>>>>>>>>> IMO its awesome. Totally. Hardly mentions bpi at all, but a reader can plainly infer that if a good anti-endotoxin makes it to market,AND endotoxin theory holds true, it could "perhaps" change the practice of medicine quite a bit. Thats "could perhaps" >"change the practice of" "potential" indications are more than most here can count to. BTW-I hear a neuprex paper is underway.(prepatory groundwork) Standard K disclaimers. All disclaimers always apply to all my notes, past present future. Never invest based on what I say. Nothing may be factual. Consider all as worthless opinion. VBG

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next